IIRT is a trusted Biocompatibility Testing Lab and Biocompatibility Test Provider offering comprehensive safety evaluation services for medical devices, biomaterials, components, and finished products. Our biocompatibility testing services help manufacturers evaluate the biological safety and suitability of materials that come into contact with the human body.
Our biocompatibility test laboratory conducts studies in a controlled and secure environment, following appropriate testing procedures, safety requirements, and applicable international standards. The objective of biocompatibility testing is to identify potential biological risks, toxic substances, adverse reactions, or harmful components associated with a medical device or material.
Biocompatibility testing is an important part of the safety evaluation and regulatory assessment of medical devices and biomaterials. Depending on the intended use, contact type, duration of contact, and nature of the device, different biological safety tests may be required.
As an experienced biocompatibility test provider, IIRT supports testing requirements ranging from the initial evaluation of new materials to product development, product release testing, periodic quality assessment, and pre-clinical or non-clinical safety evaluation.
Our experts help clients develop an appropriate testing strategy based on the characteristics and intended application of their products. Every testing programme is approached through three important stages:
Planning – Understanding the product, materials, intended use, and applicable testing requirements.
Testing – Conducting appropriate biocompatibility studies under controlled laboratory conditions.
Evaluation – Analysing and interpreting test data to support biological safety assessment and regulatory requirements.
IIRT undertakes biocompatibility safety assessment of medical devices based on applicable ISO 10993 and FDA requirements, where appropriate. Our testing capabilities cover a wide range of biological safety evaluations, including:
Physicochemical Studies
Implantation Studies
Irritation and Sensitization Testing
Systemic Toxicity Studies
Cytotoxicity Testing
Genotoxicity Testing
Immunotoxicity Studies
Toxicokinetic Studies
Hemocompatibility Testing
Reproductive Toxicity Studies
Pyrogen Testing
The exact testing requirements depend on the medical device category, material composition, nature and duration of body contact, and intended clinical application.
Depending on the product and applicable standards, commonly performed biological evaluation tests include:
Cytotoxicity testing evaluates whether materials or extracts from a medical device can cause harmful effects on living cells. IIRT can support cytotoxicity evaluations using appropriate methods such as:
Agar Overlay Test
MEM Elution Test
MTT Assay
Direct Contact Testing
Colony Formation Assay
Sensitization studies help evaluate whether exposure to a material or medical device can cause an allergic or immune-mediated response. Testing may include:
Maximization Test
Closed Patch Test (Buehler)
Local Lymph Node Assay
Irritation studies evaluate the potential of a medical device or material to cause localized irritation following contact with the relevant biological tissue. Depending on the application, studies may include:
Intracutaneous Reactivity
Dermal Irritation
Ocular Irritation
Mucosal Irritation
Oral, Rectal, Vaginal and Penile Irritation Studies
Implantation studies are performed to evaluate the local biological response to materials or medical devices intended for implantation. IIRT provides implantation testing support for different applications, including:
Intramuscular Implantation
Subcutaneous Implantation
USP/ISO Implantation Studies
Evaluation of Local Tissue Response
Genotoxicity studies help evaluate whether a material or its extracts have the potential to cause genetic damage. Depending on the product and testing requirements, evaluations may include:
Ames Test
Mouse Lymphoma Assay
In Vitro Micronucleus Test
In Vivo Micronucleus Test
Chromosome Aberration Test
Systemic toxicity studies evaluate potential adverse effects that may occur following exposure to a medical device or material. IIRT supports relevant systemic toxicity evaluations, including:
Acute Toxicity
Sub-Acute Toxicity
Sub-Chronic Toxicity
Chronic Toxicity
Pyrogen Testing
Systemic Injection Studies
Reproductive Toxicity Studies
For medical devices that come into contact with blood, hemocompatibility testing can be an important part of biological safety evaluation. IIRT provides relevant testing services, including:
Hemolysis Testing
Direct Contact Hemolysis
Indirect Contact Hemolysis
Other applicable blood-contact compatibility evaluations
IIRT also provides testing support for USP Plastic testing, including applicable USP requirements such as:
USP Plastic Class I
USP Plastic Class II
USP Plastic Class III
USP Plastic Class IV
The ISO 10993 series provides a framework for the biological evaluation of medical devices. Depending on the nature and intended use of a device, different biological endpoints may need to be considered.
Our Biocompatibility Testing Lab assists manufacturers and medical device companies in identifying relevant biological safety evaluations and developing suitable testing programmes for their products.
Choosing the right biocompatibility testing laboratory is essential for obtaining reliable data and supporting product safety and regulatory requirements. IIRT combines scientific expertise, controlled laboratory practices, and a product-specific approach to biocompatibility testing.
Our experts first understand your product, material composition, intended application, and patient contact characteristics. Based on this assessment, we recommend an appropriate biocompatibility testing plan and relevant biological safety evaluations.
Whether you are developing a new medical device, evaluating a material, preparing for regulatory submission, or conducting product safety assessments, IIRT can support your biocompatibility testing requirements with a structured and scientifically driven approach.
Biocompatibility Studies for Medical Devices under ISO 10993
| Cytotoxicity | Implantation Testing | Genotoxicity | Irritation | Systemic Toxicity |
|
Agar overlay |
AMES test |
Intracutaneous Reactivity | Acute, Sub- acute, and Pyrogen test | |
|
MEM Elution |
Intramuscular (USP/ISO) and subcutaneous Implantation |
Mouse Lymphoma |
Dermal Irritation | |
|
Direct contact |
In vitro and In vivo micronucleus |
Ocular Irritation | Sub-chronic and Chronic
|
|
|
MTT assay |
Chromosome Aberration |
Mucosa Irritation | ||
|
Colony Formation |
(Oral, Rectal, Vaginal, Penile) | Reproduction toxicity |
| Sensitization | Systemic Toxicity | Hemo- compatibility | USP Plastics |
|
Maximization Test |
Acute, Sub- acute, and Pyrogen test |
ASTM Hemolysis tests – Direct and Indirect contact |
USP I-IV |
|
Closed Patch (Buehler) |
Systemic injection |
||
|
Local lymph node assay |
Sub-chronic and Chronic |
Intracutaneous test |
|
|
Reproduction toxicity |
Implant test |
Send Enquiry
Copyright © 2023 toxicityindia.org. All rights reserved.